Literature DB >> 6104471

Lethal effect of a heterologous murein hydrolase on penicillin-treated Streptococcus sanguis.

D Horne, A Tomasz.   

Abstract

Nine strains of Streptococcus sanguis exhibited tolerance to benzylpenicillin: the growth of each strain was susceptible to penicillin with minimal inhibitory concentrations of 0.1 mug/ml or lower, but the bacteriolytic and bactericidal effects were limited in each case. The tolerance of these bacteria was also reflected in the large discrepancies between the minimal inhibitory and minimal bactericidal concentrations for benzylpenicillin. The hypothesis that a natural deficiency of endogenous murein hydrolase (autolysin) in this species accounts for the penicillin tolerance was tested by using a heterologous murein hydrolase, the C-phage-associated lysin. In seven of the strains, addition of the lysin to the culture together with penicillin or other cell wall inhibitors resulted in lysis and rapid loss of viability. The enzyme alone did not appreciably affect normally growing cultures. The irreversible effects of penicillin plus lysin were drastically reduced in the presence of the bacteriostatic agents chloramphenicol and cerulenin. Speculations based on experiments are presented for the mechanisms by which penicillin treatment sensitizes these bacteria to an exogenous lytic enzyme. Similar phenomena requiring cooperation of host factors and penicillin may occur during infection, since somewhat similar although less pronounced results were obtained by addition of human lysozyme to penicillin-treated S. sanguis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6104471      PMCID: PMC283764          DOI: 10.1128/AAC.17.2.235

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

Review 1.  Immunological properties of teichoic acids.

Authors:  K W Knox; A J Wicken
Journal:  Bacteriol Rev       Date:  1973-06

2.  Choline-containing teichoic acid as a structural component of pneumococcal cell wall and its role in sensitivity to lysis by an autolytic enzyme.

Authors:  J L Mosser; A Tomasz
Journal:  J Biol Chem       Date:  1970-01-25       Impact factor: 5.157

3.  Multiple antibiotic resistance in a bacterium with suppressed autolytic system.

Authors:  A Tomasz; A Albino; E Zanati
Journal:  Nature       Date:  1970-07-11       Impact factor: 49.962

4.  Cellular metabolism in genetic transformation of pneumococci: requirement for protein synthesis during induction of competence.

Authors:  A Tomasz
Journal:  J Bacteriol       Date:  1970-03       Impact factor: 3.490

5.  Enhanced susceptibility of penicillin-resistant staphylococci to phagocytosis after in vitro incubation with low doses of nafcillin.

Authors:  H Friedman; G H Warren
Journal:  Proc Soc Exp Biol Med       Date:  1974-07

6.  Murein hydrolases in the envelope of Escherichia coli. Properties in situ and solubilization from the envelope.

Authors:  R Hartmann; S B Bock-Hennig; U Schwarz
Journal:  Eur J Biochem       Date:  1974-01-03

7.  The role of autolysins in cell death.

Authors:  A Tomasz
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

8.  Lipids of Salmonella typhimurium and Escherichia coli: structure and metabolism.

Authors:  G F Ames
Journal:  J Bacteriol       Date:  1968-03       Impact factor: 3.490

9.  Role of autolysins in the killing of bacteria by some bactericidal antibiotics.

Authors:  H J Rogers; C W Forsberg
Journal:  J Bacteriol       Date:  1971-12       Impact factor: 3.490

10.  Purification and physical properties of group C streptococcal phage-associated lysin.

Authors:  V A Fischetti; E C Gotschlich; A W Bernheimer
Journal:  J Exp Med       Date:  1971-05-01       Impact factor: 14.307

View more
  13 in total

1.  Tolerance and efficacy of parenterally administered penicillin-streptomycin and orally administered amoxicillin or penicillin V for prophylaxis of experimentally induced streptococcal endocarditis.

Authors:  R Pujadas; E Escriva; J Jane; J Argimon; F Fernandez; P Fava; M Galera; J Garau
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

Review 2.  Antibiotic tolerance among clinical isolates of bacteria.

Authors:  E Tuomanen; D T Durack; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

3.  Reverse inoculum effect in bactericidal activity and other variables affecting killing of group B streptococci by penicillin.

Authors:  L Jokipii; P Brander; A M Jokipii
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

4.  Screening of Neisseria gonorrhoeae for tolerant response to beta-lactam antibiotics.

Authors:  L de Repentigny; P L Turgeon
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

5.  pH-dependent penicillin tolerance of group B streptococci.

Authors:  D Horne; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

Review 6.  Mechanisms of resistance to cephalosporin antibiotics.

Authors:  D M Livermore
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Effect of penicillin on the adherence of Streptococcus sanguis in vitro and in the rabbit model of endocarditis.

Authors:  F D Lowy; D S Chang; E G Neuhaus; D S Horne; A Tomasz; N H Steigbigel
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

8.  Food-borne outbreak of group G streptococcal sore throat in an Israeli military base.

Authors:  D Cohen; M Ferne; T Rouach; S Bergner-Rabinowitz
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

9.  Penicillin tolerance in nutritionally variant streptococci.

Authors:  Y Holloway; J Dankert
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

10.  Penicillin-induced effects on streptomycin uptake and early bactericidal activity differ in viridans group and enterococcal streptococci.

Authors:  M H Miller; M A el-Sokkary; S A Feinstein; F D Lowy
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.